Motilal Oswal: Biocon Q1 Logs Healthy Recovery In Biologics; Improved Demand Scenario For Generics

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.